Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months

BACKGROUND: Anti‐platelet factor 4 (PF4) antibodies that activate platelets via FcγRIIA drive the pathophysiology of vaccine‐induced immune thrombocytopenia and thrombosis (VITT). Evolution of these antibodies and their ability to activate platelets after initial treatment remains unknown. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Montague, Samantha J., Smith, Christopher W., Lodwick, Clare S., Stoneley, Charlotte, Roberts, Matthew, Lowe, Gillian C., Lester, William A., Watson, Steve P., Nicolson, Phillip L. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066380/
https://www.ncbi.nlm.nih.gov/pubmed/35515079
http://dx.doi.org/10.1002/rth2.12707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066380/
https://www.ncbi.nlm.nih.gov/pubmed/35515079
http://dx.doi.org/10.1002/rth2.12707

Ejemplares similares